Pyroglutamic acidosis in a renal transplant patient
| Autor: | John F. Fraser, Carole L. Foot, Daniel V. Mullany |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Anion gap Gastroenterology Diagnosis Differential Fatal Outcome Internal medicine medicine Humans Acidosis Transplantation Medullary Sponge Kidney business.industry Metabolic acidosis Acute Kidney Injury Middle Aged medicine.disease Kidney Transplantation Pyrrolidonecarboxylic Acid Ketoacidosis Endocrinology Nephrology Renal transplant Lactic acidosis Disease Progression Female Hemodialysis medicine.symptom business Kidney disease |
| Zdroj: | Nephrology Dialysis Transplantation. 20:2836-2838 |
| ISSN: | 1460-2385 0931-0509 |
| DOI: | 10.1093/ndt/gfi184 |
| Popis: | Metabolic acidosis is a common acid–base disorder in critically ill patients. Elucidation of the cause usually commences with the calculation of the anion gap. Increased anion gap metabolic acidosis is commonly due to lactic acidosis, renal failure, ketoacidosis as well as a multitude of drugs including toxic alcohols. Pyroglutamic acidosis (5-oxoprolinuria) is a rare cause of increased anion gap acidosis and has not previously been reported in a renal transplant patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|